| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 70, 1420-1425, Copyright © 1990 by Endocrine Society
ARTICLES |
MA Raskind, ER Peskind, RC Veith, CW Wilkinson, D Federighi and DM Dorsa
Department of Psychiatry, University of Washington School of Medicine, Seattle.
We assessed the effects of age on cholinergic regulation of the hypothalamic-pituitary-adrenal axis and other neuroendocrine systems by measuring the plasma cortisol and beta-endorphin responses to an infusion of the centrally active cholinesterase inhibitor physostigmine (0.0125 mg/kg) in 12 healthy older men (68 +/- 1.7 yr) and 9 healthy young men (25 +/- 1.4 yr). We also measured the responses to physostigmine of plasma GH, arginine vasopressin, epinephrine, and norepinephrine (NE). As estimated by comparing calculated areas under the curve, older subjects had greater cortisol (P = 0.02) and beta- endorphin (P less than 0.01) secretory responses, but a reduced GH (P less than 0.01) secretory response. The arginine vasopressin response did not differ between groups. By analysis of variance, older subjects also had a greater epinephrine response (P = 0.01). Older subjects had higher basal NE concentrations (P less than 0.05), but NE responses to physostigmine did not differ between groups. These findings suggest age- related enhancement of the cholinergic stimulatory regulation of the hypothalamic-pituitary-adrenal axis and adrenal medulla. They also confirm previous reports of reduced GH secretory response with aging in normal men.
This article has been cited by other articles:
![]() |
T. Traustadottir, P. R. Bosch, T. Cantu, and K. S. Matt Hypothalamic-Pituitary-Adrenal Axis Response and Recovery from High-Intensity Exercise in Women: Effects of Aging and Fitness J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3248 - 3254. [Abstract] [Full Text] [PDF] |
||||
![]() |
K Deguchi, I Sasaki, T Touge, M Tsukaguchi, H Takeuchi, and S Kuriyama Abnormal baroreceptor-mediated vasopressin release as possible marker in early diagnosis of multiple system atrophy J. Neurol. Neurosurg. Psychiatry, January 1, 2004; 75(1): 110 - 115. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. E. Muller, V. Locatelli, and D. Cocchi Neuroendocrine Control of Growth Hormone Secretion Physiol Rev, April 1, 1999; 79(2): 511 - 607. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |